Cargando…
Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region
Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaini...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965329/ https://www.ncbi.nlm.nih.gov/pubmed/31998133 http://dx.doi.org/10.3389/fphar.2019.01536 |
_version_ | 1783488618666393600 |
---|---|
author | Zhu, Qunyan Lu, Cuitao Jiang, Xuan Yao, Qing Jiang, Xue Huang, Zhiwei Jiang, Yina Peng, Lei Fu, Hongxing Zhao, Yingzheng |
author_facet | Zhu, Qunyan Lu, Cuitao Jiang, Xuan Yao, Qing Jiang, Xue Huang, Zhiwei Jiang, Yina Peng, Lei Fu, Hongxing Zhao, Yingzheng |
author_sort | Zhu, Qunyan |
collection | PubMed |
description | Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaining islet vascularization and innervation are impaired by enzymatic digestion in the isolation process before islet transplantation, leading to destruction of islet microvessels. These are the primary concern and major barrier for long-term islet survival and function. Thus, it is crucial to create an appropriate microenvironment for improving revascularization and islet function to achieve better transplantation outcome. Given the importance of the presence of ECM proteins for islets, we introduce recombinant human collagen (RHC) to construct a simulated ECM microenvironment. To accelerate revascularization and reduce islet injury, we add basic fibroblast growth factor (bFGF) to RHC, a growth factor that has been shown to promote angiogenesis. In order to verify the outcome, islets were treated with RHC combination containing bFGF and then implanted into kidney capsule in type 1 diabetic mouse models. After transplantation, 30-day-long monitoring displayed that 16 mg–60 ng RHC-bFGF group could serve as superior transplantation outcome. It reversed the hyperglycemia condition in host rapidly, and the OGTT (oral glucose tolerance test) showed a similar pattern with the control group. Histological assessment showed that 16 mg–60 ng RHC-bFGF group attenuated apoptosis, promoted cellular proliferation, triggered vascularization, and inhibited inflammation reaction. In summary, this work demonstrates that application of 16 mg–60 ng RHC-bFGF and islets composite enhance the islet survival, function, and long-term transplantation efficiency. |
format | Online Article Text |
id | pubmed-6965329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69653292020-01-29 Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region Zhu, Qunyan Lu, Cuitao Jiang, Xuan Yao, Qing Jiang, Xue Huang, Zhiwei Jiang, Yina Peng, Lei Fu, Hongxing Zhao, Yingzheng Front Pharmacol Pharmacology Islet transplantation is considered a potential therapeutic option to reverse diabetes. The pancreatic basement membrane contains a variety of extracellular matrix (ECM) proteins. The abundant ECM is essential for the survival of transplanted islets. However, the ECM proteins necessary for maintaining islet vascularization and innervation are impaired by enzymatic digestion in the isolation process before islet transplantation, leading to destruction of islet microvessels. These are the primary concern and major barrier for long-term islet survival and function. Thus, it is crucial to create an appropriate microenvironment for improving revascularization and islet function to achieve better transplantation outcome. Given the importance of the presence of ECM proteins for islets, we introduce recombinant human collagen (RHC) to construct a simulated ECM microenvironment. To accelerate revascularization and reduce islet injury, we add basic fibroblast growth factor (bFGF) to RHC, a growth factor that has been shown to promote angiogenesis. In order to verify the outcome, islets were treated with RHC combination containing bFGF and then implanted into kidney capsule in type 1 diabetic mouse models. After transplantation, 30-day-long monitoring displayed that 16 mg–60 ng RHC-bFGF group could serve as superior transplantation outcome. It reversed the hyperglycemia condition in host rapidly, and the OGTT (oral glucose tolerance test) showed a similar pattern with the control group. Histological assessment showed that 16 mg–60 ng RHC-bFGF group attenuated apoptosis, promoted cellular proliferation, triggered vascularization, and inhibited inflammation reaction. In summary, this work demonstrates that application of 16 mg–60 ng RHC-bFGF and islets composite enhance the islet survival, function, and long-term transplantation efficiency. Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6965329/ /pubmed/31998133 http://dx.doi.org/10.3389/fphar.2019.01536 Text en Copyright © 2020 Zhu, Lu, Jiang, Yao, Jiang, Huang, Jiang, Peng, Fu and Zhao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zhu, Qunyan Lu, Cuitao Jiang, Xuan Yao, Qing Jiang, Xue Huang, Zhiwei Jiang, Yina Peng, Lei Fu, Hongxing Zhao, Yingzheng Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title | Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title_full | Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title_fullStr | Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title_full_unstemmed | Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title_short | Using Recombinant Human Collagen With Basic Fibroblast Growth Factor to Provide a Simulated Extracellular Matrix Microenvironment for the Revascularization and Attachment of Islets to the Transplantation Region |
title_sort | using recombinant human collagen with basic fibroblast growth factor to provide a simulated extracellular matrix microenvironment for the revascularization and attachment of islets to the transplantation region |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965329/ https://www.ncbi.nlm.nih.gov/pubmed/31998133 http://dx.doi.org/10.3389/fphar.2019.01536 |
work_keys_str_mv | AT zhuqunyan usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT lucuitao usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT jiangxuan usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT yaoqing usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT jiangxue usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT huangzhiwei usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT jiangyina usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT penglei usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT fuhongxing usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion AT zhaoyingzheng usingrecombinanthumancollagenwithbasicfibroblastgrowthfactortoprovideasimulatedextracellularmatrixmicroenvironmentfortherevascularizationandattachmentofisletstothetransplantationregion |